BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score
2018 · BMC Clinical Pathology · 7 citations
https://doi.org/10.1186/s12907-018-0082-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
65
Citations
5
h-index
1
i10-index
Rebecca Heintzelman is an academic researcher from Lankenau Medical Center. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Acute Myeloid Leukemia Research & Neuroendocrine Tumor Research Advances. The author has an h-index of 5, co-authored 10 publications.
Click to start Chat